Skip to main content
. 2013 May 3;3(5):e002378. doi: 10.1136/bmjopen-2012-002378

Figure 1.

Figure 1

Flow chart showing the selection of pharmacological groups included in the specific analyses on sex and gender differences in different therapeutic areas. 1Cardiac therapy (C01), agents acting on the renin–angiotensin system (C09), sex hormones (G03), urologicals (G04), analgesics (N02), psycholeptics (N05), psychoanaleptics (N06) and ophthalmologicals (S01). 2Volume was measured in Defined Daily Doses (DDDs), except for eight ATC groups without any assigned DDD values where packages were used instead.